Experimental basis of platelet aggregation inhibition by acetylsalicylic acid.
The difference in the effectiveness of aspirin for the prevention of stroke and secondary prevention of myocardial infarction was discussed on the basis of inhibition of platelet aggregation.
D000244:Adenosine Diphosphate / Q000097:blood; D001241:Aspirin / Q000627:therapeutic use*; D002341:Carotid Artery Thrombosis / Q000097:blood; D002544:Cerebral Infarction / Q000097:blood / Q000517:prevention & control*; D003326:Coronary Circulation / Q000187:drug effects; D003327:Coronary Disease / Q000097:blood / Q000517:prevention & control*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D002546:Ischemic Attack, Transient / Q000097:blood; D009203:Myocardial Infarction / Q000097:blood / Q000517:prevention & control*; D010974:Platelet Aggregation / Q000187:drug effects*
D000244:Adenosine Diphosphate; D001241:Aspirin